Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JWHGWT
- Development stage
- Phase 3
- Lead developer
- Taichung Veterans General Hospital
- Administration
- Oral
01
Overview
JWHGWT is a Traditional Chinese Medicine (TCM) herbal powder formulation developed as an alternative treatment for relieving pain and numbness in patients with diabetic neuropathy. It has been evaluated in clinical trials for its safety and efficacy, particularly targeting symptoms associated with diabetes mellitus such as neuropathic pain. The precise composition of the herbal mixture, its mechanism of action, and active ingredients have not been disclosed in public sources. The product originates from Taichung Veterans General Hospital and is classified as a herbal medicine rather than a conventional pharmaceutical agent[1][2][3].
Beyond the preview
Go deeper on JWHGWT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JWHGWT.